Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure with Reduced Ejection Fraction: DEFINE-HF

23 May 2022 (10:48 - 11:01)
Organised by:
Congress Presentation Part of: Registries and Trial updates I Pharmacotherapy HFA Premium Access Heart Failure 2022

ESC 365 is supported by

ESC 365 is supported by